오리엔트바이오

002630KOSPI의약품 제조업

60.3 / 100

Reference Date: 2026-06-10

Financial Score14.5 / 40

News Sentiment17.8 / 25

Momentum18.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Surged 54.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Orient Bio operates in the biotechnology infrastructure sector, specializing in SPF egg production, CRO clinical trial services, and the development of bio-experimental equipment and biological materials, while adhering to international standards such as ICH, GLP, and GMP. The biotechnology industry, characterized by high added value and growth potential, is a key focus area for the company, contributing to healthcare, research, and pharmaceutical sectors.

Number of Employees

123people

Average Salary

32.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.934.0Point

PBR

0.65Industry Average 0.895.5Point

Lower than industry avg (good)

ROE

-16.82Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

12.14Industry Average 12.434.0Point

In line with industry avg

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼260.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -0.2% (declining, 2yr)

Detailed News Sentiment

9 totalPositive 5Neutral 3Negative 1Average Sentiment Score 71.1

Neutral
블랙야크강태선나눔재단, 실종아동의 날 복지부 장관 표창
Neutral
오리엔트바이오 장재진 회장, '실종아동의 날' 보건복지부 장관 표창
오리엔트바이오 회장의 실종아동 관련 수상은 기업 이미지 향상에 기여할 수 있으나, 직접적인 재무 영향은 제한적입니다.
Neutral
배송차량·택배에 실종아동 정보 부착한 단체들에 복지장관 표창
실종아동 찾기 캠페인 관련 정부 포상이 발표되었으나, 오리엔트바이오와 직접적인 연관성이 없다.

Detailed Momentum

52-week position6.0Point

52w upper range (65%)

Current 783Won52-week high 95352-week low 467

1-month return6.0Point

1m +54.13% (strong rise)

Volume trend6.0Point

Volume increasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업지배구조보고서공시2026-06-01
Neutral매출액또는손익구조30%(대규모법인은15%)이상변경2026-05-15